Tea tree oil
Identification
- Generic Name
- Tea tree oil
- DrugBank Accession Number
- DB11218
- Background
Tea tree oil is an essential oil derived mainly from the Australian native plant Melaleuca alternifolia via steam distillation of the of the leaves and terminal branches 2. It may be referred to as Melaleuca alternifolia oil. It has been a popular ingredient in a variety of household and cosmetic products due to its antiseptic, anti-inflammatory, broad-spectrum antimicrobial and antioxidant properties 1. The dermatological use of tea tree oil has been investigated by various studies, where several studies have suggested the uses of this oil for the treatment of acne vulgaris, seborrheic dermatitis, and chronic gingivitis 1. Terpene hydrocarbons and related alcohols constitute tea tree oil, with Terpinen-4-ol being the major antimicrobial component 2.
- Type
- Biotech
- Groups
- Experimental, Nutraceutical
- Synonyms
- Australian tea tree oil
- Melaleuca alternifolia (tea tree) leaf oil
- Melaleuca alternifolia (tea tree) leaf water
- Melaleuca alternifolia leaf oil
- Melaleuca alternifolia oil
- Melaleuca oil
- Narrow-leaved tea-tree leaf oil
- Narrow-leaved ti-tree leaf oil
- Narrowleaf paperbark leaf oil
- Snow-in-summer leaf oil
- Tea tree oil
- Tea tree oil australia
- Tea tree volatile oil
- Ti tree oil
- External IDs
- FEMA NO. 3902
Pharmacology
- Indication
Indicated for topical use to help protect against infection in minor cuts, scrapes, and burns. No FDA-approved therapeutic indications.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Tea tree oil exhibits antibacterial, antifungal, antiviral, and antiprotozoal activities 2. It mostly mediates bactericidal actions at concentrations of 1.0% or less in most bacteria such as Staphylococcus aureus and Escherichia coli, and causes bacteriostatic effects at lower concentrations 2. Organisms such as commensal skin staphylococci and micrococci, Enterococcus faecalis, and Pseudomonas aeruginosaemphasized text were susceptible to tea tree oil concentrations of 2% 2. It is proposed that water-soluble components of tea tree oil are capable in inducing anti-inflammatory actions; terpinen-4-ol attenuates the vasodilation and plasma extravasation associated with histamine-induced inflammation in humans 1.
- Mechanism of action
The components of tea tree oil, particularly terpinen-4-ol and α-terpineol, mediate antimicrobial actions by disrupting the structural and functional integrity of bacterial membrane. Hydrocarbons are capable of partitioning into the cell and cytoplasmic membrane of microorganisms and disrupt their vital functions, which may result in leakage of ions such as potassium, and the inhibition of respiration 2. Eventually, cell lysis may occur due to weakening of the cell wall, and loss of turgor pressure and subsequent rupture of the cytoplasmic membrane 3. The loss of 260-nm-absorbing material may be indicative of a damaged cytoplasmic membrane and loss of nucleic acids 3. In E. coli, perturbed potassium homeostasis, glucose-dependent respiration, cell morphology, and ability to exclude propidium iodide was observed.
Tea tree oil also mediates its antifungal actions in a similar way, where it alters the permeability of Candida albicans and inhibits its respiration in a dose-dependent manner 2. Plasma and mitochondrial membranes of fungal species are also thought to be negatively affected by inhibition of glucose-induced medium acidification by tea tree oil, which involves inhibition of membrane ATPase responsible for the expulsion of protons 2. Tea tree oil also inhibits the formation of germ tubes, or mycelial conversion, in C. albicans, thereby disrupting cell morphogenesis 2. Water-soluble fraction of TTO, terpinen-4-ol, and α-terpineol, can inhibit the lipopolysaccharide-induced production of the inflammatory mediators such as TNF-α, IL-1β and IL-10 by human peripheral monocytes by approximately 50% and that of prostaglandin E2 by about 30% after 40 h 2. These components of tea tree oil may also suppress superoxide production by agonist-stimulated monocytes and decrease the production of reactive oxygen species by both stimulated neutrophils and monocytes 2.
- Absorption
No pharmacokinetic data available.
- Volume of distribution
No pharmacokinetic data available.
- Protein binding
No pharmacokinetic data available.
- Metabolism
No pharmacokinetic data available.
- Route of elimination
No pharmacokinetic data available.
- Half-life
No pharmacokinetic data available.
- Clearance
No pharmacokinetic data available.
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
The 50% lethal dose for TTO in a rat model is 1.9 to 2.6 mL/kg, and doses ≤1.5 g/kg was associated with ataxia and lethargy. Dermal patches containing 10% of tea tree oil was not associated with any irritant reactions. Topically-applied tea tree oil rarely causes systemic toxicity 2. Dermal application of approximately 120 ml of undiluted tea tree oil to three cats with shaved but intact skin resulted in symptoms of hypothermia, uncoordination, dehydration, and trembling and in the death of one of the cats 2.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Alkmene Anti Spot pad Liquid 48 g/100g Topical Mann & Schroeder GmbH 2017-01-16 Not applicable US Burnaid Burn Gel Gel 10 mg/1g Topical Clear Healthcare Llc 2013-11-04 Not applicable US Jeopureun Chowon Wiae Hand sanitizer Gel 1.0 g/100mL Topical Daraeworld Co., Ltd. 2020-04-01 Not applicable US Jeopureun Chowon Wiae Hand sanitizer Liquid 1.0 g/100mL Topical Daraeworld Co., Ltd. 2020-04-01 Not applicable US Jeopureun Chowon Wiae Hand sanitizer Spray 1.0 g/100mL Topical Daraeworld Co., Ltd. 2020-04-01 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Cellskin Clean Pine Mist Tea tree oil (0.01 g/100mL) + Eucalyptus oil (0.01 g/100mL) + Grapefruit (0.05 g/100mL) Spray Topical Gtg Wellness Co., Ltd. 2020-07-01 Not applicable US Eczema Therapy Tea tree oil (0.2 g/100g) + Aloe vera leaf (0.12 g/100g) + Chamomile (0.3 g/100g) Soap Topical Golden B America, Llc. 2018-03-13 Not applicable US Elmore Oil Tea tree oil (42.5 mg/1mL) + Eucalyptus oil (38.6 mg/1mL) Oil Topical Ultra Mix (Aust) Pty Ltd 2015-02-16 Not applicable US Elmore Oil Tea tree oil (42.5 mg/1mL) + Eucalyptus oil (38.6 mg/1mL) Oil Topical Elmore Oil Company Pty Ltd 2013-07-01 Not applicable US Euky Bear Antiseptic Spray Tea tree oil (18 mg/ml) + Eucalyptus oil (136 mg/ml) + Lavender oil (9 mg/ml) Spray Topical ROSLIND ENTERPRISE (M) SDN. BHD. 2020-09-08 Not applicable Malaysia - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Alkmene Anti Spot pad Tea tree oil (48 g/100g) Liquid Topical Mann & Schroeder GmbH 2017-01-16 Not applicable US Burnaid Burn Gel Tea tree oil (10 mg/1g) Gel Topical Clear Healthcare Llc 2013-11-04 Not applicable US Cellskin Clean Pine Mist Tea tree oil (0.01 g/100mL) + Eucalyptus oil (0.01 g/100mL) + Grapefruit (0.05 g/100mL) Spray Topical Gtg Wellness Co., Ltd. 2020-07-01 Not applicable US Eczema Therapy Tea tree oil (0.2 g/100g) + Aloe vera leaf (0.12 g/100g) + Chamomile (0.3 g/100g) Soap Topical Golden B America, Llc. 2018-03-13 Not applicable US Elmore Oil Tea tree oil (42.5 mg/1mL) + Eucalyptus oil (38.6 mg/1mL) Oil Topical Elmore Oil Company Pty Ltd 2013-07-01 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- VIF565UC2G
- CAS number
- 68647-73-4
References
- General References
- Pazyar N, Yaghoobi R, Bagherani N, Kazerouni A: A review of applications of tea tree oil in dermatology. Int J Dermatol. 2013 Jul;52(7):784-90. doi: 10.1111/j.1365-4632.2012.05654.x. Epub 2012 Sep 24. [Article]
- Carson CF, Hammer KA, Riley TV: Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev. 2006 Jan;19(1):50-62. doi: 10.1128/CMR.19.1.50-62.2006. [Article]
- Carson CF, Mee BJ, Riley TV: Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob Agents Chemother. 2002 Jun;46(6):1914-20. [Article]
- External Links
- PubChem Substance
- 347911156
- 69627
- Wikipedia
- Tea_tree_oil
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 4 Completed Treatment Non Specific Vaginitis 1 4 Completed Treatment Seborrheic Blepharitis 1 2 Completed Prevention End Stage Renal Disease, Requiring Dialysis 1 2 Completed Treatment Blepharitis 1 2 Completed Treatment Periodontitis 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Swab Topical 25 % Liquid Topical 48 g/100g Gel Topical 10 mg/1g Spray Topical Kit; liquid; oil; patch Topical Gel Vaginal Gel Topical 1.0 g/100mL Liquid Topical 1.0 g/100mL Spray Topical 1.0 g/100mL Gel Topical 23 % Cream Topical Oil Topical Soap Topical Liquid Topical Soap Topical 0.5 g/100g Liquid Topical 100 % Oil Topical 15 mL/15mL Ointment Topical 2.5 g/50g Ointment Topical 50 mg/1g Liquid Topical 4 % Cream Topical 5 g/100g Oil Topical 25 mL/25mL Oil Topical 50 mL/50mL Ointment Topical 3 g/50g Solution Topical Cloth Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
Property Value Source water solubility Sparingly soluble Carson CF, Mee BJ, Riley TV. Mechanism of Action of Melaleuca alternifolia (Tea Tree) Oil on Staphylococcus aureus Determined by Time-Kill, Lysis, Leakage, and Salt Tolerance Assays and Electron Microscopy. Antimicrobial Agents and Chemotherapy. 2002;46(6):1914-1920. doi:10.1128/AAC.46.6.1914-1920.2002.
Drug created at December 03, 2015 16:51 / Updated at February 20, 2024 23:55